Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 84,179 | 76,684 | 71,234 | 74,018 | 71,675 |
| Cost of Goods | 12,878 | 13,031 | 12,406 | 12,131 | 14,534 |
| Gross Profit | 71,301 | 63,653 | 58,828 | 61,887 | 57,141 |
| Operating Expenses | 58,700 | 59,061 | 59,098 | 52,344 | 58,760 |
| Operating Income | 13,479 | 4,623 | 136 | 9,674 | -1,085 |
| Other Income | -6,630 | -36,051 | -38,775 | -572 | 25,422 |
| Pre-tax Income | 6,849 | -31,428 | -38,639 | 9,102 | 24,337 |
| Income Tax | 349 | 920 | 1,966 | 2,024 | -755 |
| Net Income Continuous | 6,500 | -32,348 | -40,605 | 7,078 | 25,092 |
| Net Income | $6,500 | $-32,348 | $-40,605 | $7,078 | $25,092 |
| EPS Basic Total Ops | 0.03 | -0.17 | -0.21 | 0.04 | 0.13 |
| EPS Basic Continuous Ops | 0.03 | -0.17 | -0.22 | 0.03 | 0.14 |
| EPS Diluted Total Ops | 0.03 | -0.17 | -0.21 | 0.02 | 0.13 |
| EPS Diluted Continuous Ops | 0.03 | -0.17 | -0.22 | 0.03 | 0.13 |
| EBITDA(a) | $15,522 | $6,902 | $2,412 | $11,969 | $1,111 |